Key Points of the Announcement
- Acquisition of Quoted Securities: mDR Limited and its subsidiaries (“the Group”) have acquired quoted securities with a total value of approximately S\$19.2 million over the period from 3 December 2025 to 11 December 2025.
- Sale of Quoted Securities: Within the same period, the Group sold quoted securities amounting to approximately S\$4.3 million (based on historical cost).
- Impact on Net Tangible Assets:
- The acquisition of quoted securities represents 12.9% of the Group’s latest audited net tangible assets.
- The disposal represents 2.9% of the audited net tangible assets.
- Aggregate Investments:
- After the acquisition, the aggregate cost of the Group’s quoted investments increased from S\$286.99 million to S\$290.58 million.
- This now represents 195.8% of the Group’s latest audited consolidated net tangible assets (as at 31 December 2024: S\$148.43 million).
- Market Value:
- The total market value of the Group’s quoted investments increased to S\$211.55 million after the acquisition.
- Provision for Diminution in Value:
- No provision for diminution in value of quoted investments has been made.
Important Information for Shareholders
- Material Transactions: The acquisition and disposal of quoted securities in such significant amounts (relative to net tangible assets) is noteworthy and may have implications for the Group’s risk profile and capital allocation strategy.
- Capital Allocation: The aggregate cost of quoted investments is now nearly double the Group’s net tangible assets, a factor that could materially impact the Group’s balance sheet and its ability to respond to future financial challenges.
- Potential Price Sensitivity:
- Changes in the market value of these investments may cause significant volatility in the Group’s reported financial position.
- Investors should note the concentration of assets in quoted securities, which may expose the Group to market risk.
- No Impairment Recorded: The lack of provision for diminution in value suggests management believes the investments have not suffered significant declines in market value, though shareholders should continue to monitor for any future impairments.
Detailed Financial Impact
|
Before Acquisition |
After Acquisition |
| Aggregate Cost of Quoted Investments (S\$’000) |
286,986 |
290,584 |
| Aggregate Cost as % of Net Tangible Assets |
193.4% |
195.8% |
| Total Market Value of Quoted Investments (S\$’000) |
209,015 |
211,554 |
| Provision for Diminution in Value (S\$’000) |
0 |
0 |
| Net Tangible Assets (as at 31 Dec 2024; S\$’000) |
148,431 |
Investor Considerations
- Shareholders should closely monitor further announcements relating to the performance of the quoted investments, as changes in value or future provisions for diminution could affect the Group’s financial health and share price.
- The Group’s substantial holding of quoted securities may indicate a shift in investment strategy or risk appetite, which could impact future earnings volatility.
- Any significant change in the value of these investments or strategic decisions regarding them may be price sensitive and could impact the valuation of mDR Limited shares.
Disclaimer: This article is based on public disclosures made by mDR Limited. Investors are advised to conduct their own due diligence and consult professional advisors before making investment decisions. The information provided herein does not constitute financial advice or a recommendation to buy or sell securities.
View MDR Limited Historical chart here
